AAAAAA

   
Results: 1-25 | 26-35 |
Results: 26-35/35
MALIGNANT HISTIOCYTOSIS IN THE LEUKEMIC STAGE - A NEW ENTITY (M5C-AML) IN THE FAB CLASSIFICATION
Authors: LAURENCET FM CHAPUIS B ROUXLOMBARD P DAYER JM BERIS P
Citation: Fm. Laurencet et al., MALIGNANT HISTIOCYTOSIS IN THE LEUKEMIC STAGE - A NEW ENTITY (M5C-AML) IN THE FAB CLASSIFICATION, Leukemia, 8(3), 1994, pp. 502-506
POSTINFECTION TRANSITORY PARTIAL CORRECTION OF THROMBOCYTOPENIA IN MAY-HEGGLIN ANOMALY
Authors: BERIS P CLOSE P LANDIS JR MORABIA A
Citation: P. Beris et al., POSTINFECTION TRANSITORY PARTIAL CORRECTION OF THROMBOCYTOPENIA IN MAY-HEGGLIN ANOMALY, American journal of hematology, 46(1), 1994, pp. 60-60
HEMATOLOGIC, CLINICAL, AND CYTOGENETIC ANALYSIS IN 109 PATIENTS WITH PRIMARY MYELODYSPLASTIC-SYNDROME - PROGNOSTIC-SIGNIFICANCE OF MORPHOLOGY AND CHROMOSOME FINDINGS
Authors: PARLIER V VANMELLE G BERIS P SCHMIDT P TOBLER A HALLER E BELLOMO MJ
Citation: V. Parlier et al., HEMATOLOGIC, CLINICAL, AND CYTOGENETIC ANALYSIS IN 109 PATIENTS WITH PRIMARY MYELODYSPLASTIC-SYNDROME - PROGNOSTIC-SIGNIFICANCE OF MORPHOLOGY AND CHROMOSOME FINDINGS, Cancer genetics and cytogenetics, 78(2), 1994, pp. 219-231
MYELODYSPLASIA IN A PATIENT WITH PREEXISTING PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA - A CLONAL DISEASE ORIGINATING FROM WITHIN A CLONAL DISEASE
Authors: LONGO L BESSLER M BERIS P SWIRSKY D LUZZATTO L
Citation: L. Longo et al., MYELODYSPLASIA IN A PATIENT WITH PREEXISTING PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA - A CLONAL DISEASE ORIGINATING FROM WITHIN A CLONAL DISEASE, British Journal of Haematology, 87(2), 1994, pp. 401-403
THE LIMIT OF DOSE-INTENSIFICATION IN THE TREATMENT OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA DESPITE GROWTH-FACTOR THERAPY
Authors: WERNLI M FEY MF TOBLER A VONROHR A BARGETZI M TICHELLI A FEHR J GMUR J JACKY E BERIS P CHAPUIS B HESS U DELACRETAZ F JOTTERAND M SCHAPIRA M CAVALLI F MAIBACH R RUFENER B GRATWOHL A
Citation: M. Wernli et al., THE LIMIT OF DOSE-INTENSIFICATION IN THE TREATMENT OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA DESPITE GROWTH-FACTOR THERAPY, Blood, 84(10), 1994, pp. 10000144-10000144
EVIDENCE THAT POLYCLONAL IG SECRETION IN A CASE OF B-CELL CLL IS THE RESULT OF IL-2 PRODUCTION BY THE PROLIFERATING MONOCLONAL B-CELLS
Authors: MOUZAKI A MATTHES T MIESCHER PA BERIS P
Citation: A. Mouzaki et al., EVIDENCE THAT POLYCLONAL IG SECRETION IN A CASE OF B-CELL CLL IS THE RESULT OF IL-2 PRODUCTION BY THE PROLIFERATING MONOCLONAL B-CELLS, Blood, 84(10), 1994, pp. 10000181-10000181
ETOPOSIDE AND SECONDARY HEMATOLOGICAL MALIGNANCIES - COINCIDENCE OR CAUSALITY
Authors: ZULIAN GB BELLOMO MJ CABROL C BERIS P MERMILLOD B ALBERTO P
Citation: Gb. Zulian et al., ETOPOSIDE AND SECONDARY HEMATOLOGICAL MALIGNANCIES - COINCIDENCE OR CAUSALITY, Annals of oncology, 4(7), 1993, pp. 559-566
ADOPTIVE IMMUNOTHERAPY FOR RECURRENT CML AFTER BMT
Authors: HELG C ROUX E BERIS P CABROL C WACKER P DARBELLAY R WYSS M JEANNET M CHAPUIS B ROOSNEK E
Citation: C. Helg et al., ADOPTIVE IMMUNOTHERAPY FOR RECURRENT CML AFTER BMT, Bone marrow transplantation, 12(2), 1993, pp. 125-129
RECOMBINANT-HUMAN-ERYTHROPOIETIN AS ADJUVANT TREATMENT FOR AUTOLOGOUSBLOOD DONATION - A PROSPECTIVE-STUDY
Authors: BERIS P MERMILLOD B LEVY G LAUBRIAT M SOULIERLAUPER M TULLEN E HUGLI A MIESCHER PA
Citation: P. Beris et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN AS ADJUVANT TREATMENT FOR AUTOLOGOUSBLOOD DONATION - A PROSPECTIVE-STUDY, Vox sanguinis, 65(3), 1993, pp. 212-218
MYELODYSPLASIA IN A PATIENT WITH PREEXISTING PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA - A CLONAL DISEASE WITHIN A CLONAL DISEASE
Authors: LONGO L BESSLER M BERIS P SWIRSKY D LUZZATTO L
Citation: L. Longo et al., MYELODYSPLASIA IN A PATIENT WITH PREEXISTING PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA - A CLONAL DISEASE WITHIN A CLONAL DISEASE, British Journal of Haematology, 84, 1993, pp. 34-34
Risultati: 1-25 | 26-35 |